EBV BZLF1 54-64 Peptide (HLA-B*35:01) - EPLPQGQLTAY

The EBV BZLF1 54-64 peptide (EPLPQGQLTAY) is a defined HLA-B*35:01-restricted epitope derived from the Epstein-Barr Virus immediate-early protein BZLF1 (Zta), a key regulator of the viral lytic cycle. This peptide is widely used for the stimulation and detection of EBV-specific CD8+ T cells, enabling reliable immune monitoring in infectious disease and cancer immunology research.

As a well-characterized MHC class I epitope, EBV BZLF-1 54-64 is relevant for studying cytotoxic T cell responses against lytic EBV infection. The sequence EPLPQGQLTAY has been used in immunological assays to evaluate antigen-specific responses, including ELISPOT, ICS, and cytotoxicity assays, supporting functional analysis of EBV-specific immunity.

The Epstein-Barr Virus (EBV) BZLF1 Trans-activator protein Peptide is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The BZLF1 Trans-activator protein Peptide, H-EPLPQGQLTAY-OH (Uniprot: P03206 aa: 54-64) from JPT is produced under strict quality control and quality management.

EBV BZLF1 54-64 Peptide (HLA-B*35:01) - EPLPQGQLTAY - Specifications

• Peptide sequence: H-EPLPQGQLTAY-OH
• Amount: 1 mg
• Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
• Delivery Format: Freeze-dried in plastic vial
• Application(s): T-cell immunity
• Condition(s)/Topic(s): Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma, Infectious mononucleosis
• Standard Delivery Time: approx. 10 days

Visit our webpage for more information on Peptide Tools to Study EBV

The EBV BZLF1 54-64 peptide is optimized for reproducible performance in immunological assays targeting EBV-specific cytotoxic T lymphocyte (CTL) responses. Its defined sequence and HLA-B*35:01 restriction ensure consistent antigen presentation and reliable experimental outcomes across studies.

Applications

• ELISPOT and FluoroSpot assays
• Intracellular cytokine staining (ICS)
• Cytotoxic T lymphocyte (CTL) assays
• T cell proliferation assays

Why choose this EBV BZLF1 54-64 peptide?

• Defined HLA-B*35:01-restricted epitope (EPLPQGQLTAY)
• Reliable stimulation of EBV-specific CD8+ T cells
• Relevant for studying lytic EBV immune responses
• High-quality synthesis under strict quality control

Your Custom or Scrambled Antigen Peptide!

Do you need a scrambled version of this antigen peptide?
We can produce scrambled versions for all our antigen peptides and other peptide sequences. These scrambled peptide versions are cross-checked against the Uniprot database to ensure that the scrambled sequence does not correspond to any natural sequence. Have a look at Scrambled Antigen Peptides!

Are you interested in other antigen peptides?
Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!